Lumbar Vertebra Collapse- First Manifestation of Renal Cell Carcinoma: A Case Report
Asian Journal of Research and Reports in Urology,
Renal cell carcinoma is the most common urological malignancy having aggressive and unpredictable metastatic potential. In the available literature, a number of cases of isolated metastasis to the spine from renal cell carcinoma have been described, but there is a dearth of literature regarding a case in which symptoms from the metastasis of a renal cell carcinoma preceded the detection of the primary tumor. We present a unique case of our knowledge in which a young patient presents with lumbar vertebra collapse for which he was managed and subsequently diagnosed with renal clear cell carcinoma with spinal metastasis.
- Renal cell carcinoma
- spinal metastasis
- vertebra collapse
How to Cite
Rory J Petteys, Steven M Spitz, Rory Goodwin C, et al. Factors associated with improved survival following surgery for renal cell carcinoma spinal metastases. Neurosurg Focus. 2016;41(2):E13.
Jacobsen KD, Follerås G, Fosså SD. Metastases from renal cell carcinoma to the humerus or the shoulder girdle. Br J Urol. 1994;73:124–128.
Smith EM, Kursh ED, Makley J, Resnick MI. Treatment of osseous metastases secondary to renal cell carcinoma. J Urol. 1992;148:784–7.
Motzer RJ, Bander NH, Nanus DM. Medical progress: renal-cell carcinoma. New England Journal of Medicine. 1996;335(12)865–875,.
Lam JS, Shvarts O, Leppert JT, Pantuck AJ, Figlin RA, Belldegrun AS. Postoperative surveillance protocol for patients with localized and locally advanced renal cell carcinoma based on a validated prognostic nomogram and risk group stratification system. Journal of Urology. 2005;174(2):466–472.
Gao J, Li Y, Yang Z, Wang R. Intramedullary spinal cord metastasis of renal cell carcinoma 6 years following the nephrectomy. Turkish Neurosurgery. 2014;24(2):294–296.
Jasper Decoene, Filip Ameye, Evelyne Lerut, et al. Renal cell carcinoma with synchronous metastasis to the calcaneus and metachronous metastases to the ovary and gallbladder. Case Reports in Medicine; 2011.
Mehdi Borni, Anis Abdehedi, Brahim Kammoun, et al. A first spinal metastasis manifestation of a renal cell carcinoma: A case report and review of the literature. Elsevier Journal Urology case report. 2018;207:8-79.
Kumar RM, Aziz T, Jamshaid H, Gill J, Kapoor A. Metastatic renal cell carcinoma without evidence of a primary renal tumour: Curr Oncol. 2014;21(3):e521–e524.
Agnihotri S, Kumar J, Jain M, Kapoor R, Mandhani A. Renal cell carcinoma in India demonstrates early age of onset and a late stage of presentation. Indian J Med Res 2014;140(5):624-9.
Patchell RA, Tibbs PA, Regine WF, Payne R, Saris S, et al. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: A randomized trial. Lancet. 2005;366:643–8.
Tatsui CE, Suki D, Rao G, Kim SS, Salaskar A, Hatiboglu MA, et al. Factors affecting survival in 267 consecutive patients undergoing surgery for spinal metastasis from renal cell carcinoma. J Neurosurg Spine. 2014;20:108–116.
Ulmar B, Naumann U, Catalkaya S, Muche R, Cakir B, Schmidt R, et al. Prognosis scores of tokuhashi and tomita for patients with spinal metastases of renal cancer. Ann Surg Oncol. 2007;14:998–1004.
Sakaura H, Hosono N, Mukai Y, Ishii T, Yonenobu K, Yoshikawa H. Outcome of total en bloc spondylectomy for solitary metastasis of the thoracolumbar spine. J Spinal Disord Tech. 2004;17:297–300.
Ulmar B, Catalkaya S, Naumann U, Gerstner S, Cakir B,Schmidt R, et al. Surgical treatment and evaluation of prognostic factors in spinal metastases of renal cell carcinoma. Z Orthop Ihre Grenzgeb. 2006;144:58–67.
Tomita K, Kawahara N, Kobayashi T, Yoshida A, Murakami H, Akamaru T. Surgical strategy for spinal metastases. Spine. 2001;26:298–306.
Kollender Y, Bickels J, Price WM, et al. Metastatic renal cell carcinoma of bone: Indications and technique of surgical intervention. Journal of Urology. 2000;164(5):1505– 1508.
James Langdon, Adam Way, Samuel Heaton, Jason Bernard, et al. The management of spinal metastases from renal cell carcinoma. Ann R Coll Surg Engl. 2009;91:649–652.
Xia Y, Zhang Q, Zhen Q, Zhao Y, Liu N, Li T, et al. Negative regulation of tumor-infiltrating NK cell in clear cell renal cell carcinoma patients through the exosomal pathway. Oncotarget. 2017;8(23):37783–95.
Uzzo RG, Rayman P, Kolenko V, Clark PE, Bloom T, Ward AM, et al. Mechanisms of apoptosis in T cells from patients with renal cell carcinoma. Clin Cancer Res. 1999;5(5):1219–29.
Dadian G, Riches PG, Henderson DC, Taylor A, Moore J, Atkinson H, et al. Immunological parameters in peripheral blood of patients with renal cell carcinoma before and after nephrectomy. Br J Urol. 1994;74(1):15–22.
Renner A, et al. Is cytoreductive nephrectomy still a standard of care in metastatic renal cell carcinoma? J Kidney Cancer VHL. 2019;6(1):1–7.
Posadas EM, Limvorasak S, Figlin RA. Targeted therapies for renal cell carcinoma. Nat Rev Nephrol. 2017;13(8):496–511.
Rini BI, et al. Pembrolizumab plus Axitinib versus sunitinib for advanced renal-cell carcinoma. N Engl J Med. 2019;380(12):1116–27.
Motzer RJ, Penkov K, Haanen J, Rini B, Albiges L, Campbell MT, et al. Avelumab plus Axitinib versus sunitinib for advanced renal-cell carcinoma. N Engl J Med. 2019;380 (12):1103–15.
Motzer RJ, Powles T, Atkins MB, Escudier B, McDermott DF, Suarez C, et al. IMmotion151: A randomized phase III study of Atezolizumab plus Bevacizumab vs sunitinib in untreated metastatic renal cell carcinoma (mRCC). J Clin Oncol. 2018;36:578.
Junpeng Wang, Xin Li, Xiaoqiang Wu, et al. Role of immune checkpoint inhibitor-based therapies for metastatic renal cell carcinoma in the first-line setting: A Bayesian network analysis. EBioMedicine. 2019;47:78–88.
Abstract View: 36 times
PDF Download: 18 times